(Q40148453)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24202856%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

The use of digital images improves reproducibility of the ki-67 labeling index as a proliferation marker in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24202856%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24202856%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Bence Kővári

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24202856%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

András Vörös

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24202856%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Erika Csörgő

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24202856%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Péter Lázár

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24202856%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Gyöngyi Kelemen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24202856%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

1 reference

8 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24202856%20AND%20SRC:MED&resulttype=core&format=json

Pathology Oncology Research

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24202856%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24202856%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24202856%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

391-397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24202856%20AND%20SRC:MED&resulttype=core&format=json

Proliferation marker Ki-67 in early breast cancer

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Ki67 in breast cancer: prognostic and predictive potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Prognostic significance of tumor cell proliferation analyzed in fine needle aspirates from primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Measuring proliferation in breast cancer: practicalities and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Ki-67 expression gives additional prognostic information on St. Gallen 2007 and Adjuvant! Online risk categories in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

St. Gallen 2011: Summary of the Consensus Discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

An intra- and interobserver reproducibility analysis of the Ki-67 proliferation marker assessment on core biopsies of breast cancer patients and its potential clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9708-Z

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies

21 January 2018

1 reference

12 December 2020

Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer

1 reference

12 December 2020

Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67

1 reference

12 December 2020

Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis

1 reference

12 December 2020

Who would have thought a single Ki67 measurement would predict long-term outcome?

1 reference

12 December 2020

Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index

1 reference

12 December 2020

10.1007/S12253-013-9708-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24202856%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference